Ultragenyx Pharmaceutical (NasdaqGS:RARE) Q3 2025 Earnings Call November 04, 2025 05:00 PM ET Company ParticipantsMehdi Goudarzi - Biotech Equity ResearchMaxwell Skor - Biotechnology Equity ResearchGavin Gartner - Managing Director and Biotechnology Equity ResearchGena Wang - Managing Director and Biotech Equity ResearchHoward Horn - CFOEmil Kakkis - CEO and PresidentErik Harris - Chief Commercial OfficerJoshua Higa - VP of Investor RelationsTazeen Ahmad - Managing DirectorEric Crombez - CMOYigal Nochomovit ...